For anyone who missed posts by Joolsg and SueJohnson about AASM's drafting work last year, there is a new Clinical Practice Guideline from the AASM advising against the use of dopamine agonists for RLS except in some exceptional circumstances, strongly recommending iron therapy, and advising for gabapentinoids and low dose opioids.
Here is a summary by Drs Berkowski and Winkelman, which includes a link to the full CPG: